Regulatory news note. A pediatric spinal mobility trial in cerebral palsy uses NDT Bobath therapy and exergaming to explore therapy options and device implications for future regulation.
Publication context: as of February 20 2026 the study profile lists the conditions as Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia. Interventions include NDT Bobath Therapy; Sitting Exergaming; Standing Exergaming. The sponsor is Wroclaw University of Health and Sport Sciences and the study is not yet recruiting. A ClinicalTrials.gov record is provided for reference. The record link appears on the public registry for transparency and tracking by clinicians, families and regulators.
What changes in pediatric spinal mobility research does this trial profile indicate?
The profile introduces a three arm approach that blends traditional therapy with digital modalities. NDT Bobath Therapy is described as an intervention alongside two exergaming formats that involve sitting and standing positions. The three arms of this trial reflect a comparative setup that can help regulators and researchers understand how a pediatric rehabilitation program might integrate software driven devices. The sponsor is the Wroclaw University of Health and Sport Sciences and the trial is listed as not yet recruiting. The ClinTrials.gov reference provides a public record for oversight and future updates, which is essential for regulatory planning in pediatric device related research.
What interventions are used?
The study lists three interventions: NDT Bobath Therapy; Sitting Exergaming; Standing Exergaming. NDT Bobath Therapy represents conventional neurodevelopmental therapy oriented rehabilitation. Sitting Exergaming and Standing Exergaming introduce interactive digital activities that may be delivered through specialized equipment or consumer devices configured for clinical use. The presence of exergaming raises regulatory questions about software as a medical device and the safety requirements for pediatric populations. The text notes not yet recruiting status and sponsor details.
Who is affected by these interventions?
According to the source the trial targets children with Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia. These conditions involve mobility impairment and can be associated with limited spinal mobility. The combination of manual therapy and digital tools aims to address posture and movement while offering regulators a view into how such therapies might be implemented in pediatric care. The sponsor is a Polish university and the study remains not yet recruiting. ClinTrials.gov serves as a public registry for families and clinicians and supports regulatory oversight as new treatment modalities emerge.
What are the regulatory implications for pediatric exergaming devices?
Exergaming software used in a therapy context may fall under software as a medical device depending on jurisdiction. This trial illustrates how a traditional therapy approach might be augmented by digital tools in a pediatric setting. Regulators will consider intended use safety data data handling and user training for both hardware and software components. Because enrollment has not begun there are no efficacy data yet but the public record supports early engagement and planning for device classification labeling and post market obligations if the therapy enters routine clinical use and safety is demonstrated.
What is known about the study design and oversight?
The source text does not specify design features such as randomization or outcome endpoints. It does indicate three intervention arms and identifies the sponsor andNot yet recruiting status. The ClinTrials.gov entry serves as the primary registry for updates on enrollment amendments and safety notices. Regulatory teams should monitor such records for potential changes that could affect device or software classification and for any safety communications that may arise as the study progresses.
Risk and safety considerations for pediatric exergaming therapies
While no safety results are provided in the source the guidance for pediatric device research emphasizes risk assessment. Exergaming platforms should include age appropriate content clear instructions and safeguards to prevent motion related injuries. When combined with a therapy such as Bobath documentation of adverse events and caregiver training becomes important to maintain safety oversight for participants.
What happens next for this trial?
If enrollment proceeds the sponsor must maintain regulatory reporting and ensure that any software or hardware used is appropriately classified and approved for pediatric use. The ClinTrials.gov registry will be updated to reflect enrollment status changes protocol amendments and safety advisories. Clinicians and regulators should use the provided link to ClinTrials.gov for ongoing information about the study and its milestones.
FAQ
- 1. Which conditions does the trial include? The trial lists Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia as conditions.
- 2. What interventions are used? The study lists NDT Bobath Therapy Sitting Exergaming and Standing Exergaming.
- 3. What is the trial status and sponsor? The trial is not yet recruiting and is sponsored by Wroclaw University of Health and Sport Sciences; ClinTrials.gov provides the reference link.
Conclusion
In summary this profile shows a hybrid pediatric mobility trial that merges established therapy with digital exergaming. For regulatory audiences this example underscores the need to map out device and software classifications labeling and safety considerations early in study design. Not yet recruiting means no clinical outcomes are available yet but the public record will guide regulatory planning and potential future device approvals or clearances if results become favorable and if safety is established.
Disclaimer This article is intended for medical and regulatory professionals. It is not legal advice. Regulations vary by jurisdiction and may change over time. Always consult with regulatory counsel for specific guidance.
https://clinicaltrials.gov/study/NCT07421505?term=medical+device